At a glance
ClinicalIndex Comparison RecordN/ACompleted· 901 enrolled
Drug / intervention
Inhaled corticosteroiddrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Non-interventional, Cross-sectional, Multicenter Study to Describe the Exacerbations Profile of COPD Patients Treated With ICS in a Real-life Primary Care Population in Spain. OPTI Study.
In Brief
An observational study evaluating Inhaled corticosteroid for Pulmonary Disease, Chronic Obstructive. Completed, enrolled 901 participants across 169 sites.
Detailed Summary
This non-Interventional, descriptive, cross-sectional cohort and multicentre study will be conducted with COPD patients attended at Spanish Primary Care offices.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPulmonary Disease, Chronic Obstructive
CountriesSpain
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
First PostedAug 2018
Enrollment StartAug 2018
Primary CompletionJan 2020
TodayJul 2026
First PostedAug 2, 2018
Enrollment StartAug 14, 2018
Primary CompletionJan 31, 2020
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 7.9 years ago
Interventions
Inhaled corticosteroiddrug
Drug